Drug-Diagnostics Co-Development in Oncology

The idea of combining drugs and diagnostics in oncology is not new. When the selective estrogen receptor modulator tamoxifen was developed in the 1970’s for the treatment of breast cancer a positive correlation between receptor status and treatment outcome was found. As a result of this research, it...

Full description

Saved in:
Bibliographic Details
Main Author: Jan Trost Jorgensen
Format: Online
Language:English
Published: Frontiers Media SA 2021
Subjects:
Online Access:18664
Tags: Add Tag
No Tags, Be the first to tag this record!